• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

2019 Cochrane Review Update: Does Corticosteroid Treatment Decrease Death Due to Sepsis?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Corticosteroids has been used for decades to treat sepsis
  • In this update to a 2004 Cochrane review, Annane et al. (Cochrane Systematic Reviews, 2019) assessed the effects of corticosteroids on death in children and adults with sepsis

METHODS:

  • Systematic review and meta-analysis
  • Data sources
    • CENTRAL, MEDLINE, Embase, LILACS, ClinicalTrials.gov, ISRCTN, and the WHO Clinical Trials Search Portal
    • Unpublished data from the authors of some trials were obtained
  • Inclusion criteria
    • RCTs that included:  Corticosteroids versus placebo or usual care (antimicrobials, fluid replacement, and vasopressor therapy as needed) in children and adults with sepsis | Continuous infusion versus intermittent bolus of corticosteroids
  • Study design and data analysis
    • All review authors screened and selected studies for inclusion
    • One author extracted data, which was checked by the others, and by the lead author of the primary study when possible
    • The methodological quality of trials was assessed using Grade criteria

RESULTS:

  • Total of 61 trials | 12,192 participants
    • Participants (children vs adults): 6 only children | 2 with both children and adults | Remainder adults only
    • 9 studies ongoing (to be reviewed in the future)
    • 19 trials were judged as being at low risk of bias

Corticosteroids Versus Placebo or Usual Care

  • Corticosteroids probably results in reduced 28-day mortality
    • Risk ratio (RR) 0.91 (95% CI, 0.84 to 0.99; moderate-certainty evidence)
  • Corticosteroids may result in little to no difference in long-term mortality
    • RR 0.97 (95% CI, 0.91 to 1.03; low-certainty evidence)
  • Corticosteroids probably slightly reduce hospital mortality
    • RR 0.90 (95% CI, 0.82 to 0.99; moderate-certainty evidence)
  • Corticosteroids reduced length of ICU stay
    • mean difference (MD) -1.07 days (95% CI, -1.95 to -0.19; high-certainty evidence)
  • Corticosteroids resulted in a reduction in length of hospital stay for all participants
    • MD -1.63 days (95% CI, -2.93 to -0.33; high-certainty evidence)
  • Risks associated with corticosteroids
    • Increased risk for muscle weakness: RR 1.21 (95% CI, 1.01 to 1.44; high-certainty evidence)
    • Increased risk for hypernatremia: RR 1.66 (95% CI, 1.34 to 2.06; high-certainty evidence
    • Probable increase for hyperglycemia: RR 1.20 (95% CI, 1.10 to 1.31; moderate-certainty evidence)
  • Study did not find an increased risk for the following
    • Superinfection | Gastroduodenal bleeding | Stroke | Cardiac events | Neuropsychiatric events

Continuous Infusion of Corticosteroids vs Intermittent Bolus

  • Uncertain effects of continuous infusion vs intermittent bolus administration (certainty of evidence for all outcomes was very low)

Subgroup Analysis

  • Age: No difference based on child vs adult
  • Severity of sepsis: Septic shock, ARDS and community‐acquired pneumonia more likely to derive a survival benefit than less severe sepsis (barely statistically significant)

CONCLUSION:

  • The use of corticosteroids probably reduces 28-day and hospital mortality for patients with sepsis
    • There may not be a difference in long-term mortality
  • Corticosteroid treatment resulted in reductions in ICU and hospital length of stay
  • The authors recognize that recent studies show benefit of corticosteroids on shock reversal (hemodynamic stability ≤24 hours) in patients with septic shock
    • However, this present systematic review included trial data that were not previously included (non-English or non-published)
    • This study may not have found the same benefit due to inclusion of “qualitatively and quantitatively better data than were provided previously”

Learn More – Primary Sources:

Corticosteroids for treating sepsis in children and adults

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Try it Free  »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

SMFM & CMQCC Guidelines: Making the Diagnosis of Sepsis in Pregnancy
SMFM & CMQCC Guidelines: Management of Sepsis in Pregnancy
Sepsis and Sepsis-Related Maternal Mortality in the U.S. – Does it Happen More Than We Think?
Do Mandated Sepsis Procedures Reduce Sepsis-Related Deaths?
Does Penalizing Hospitals for Acquired Conditions Actually Lead to Performance Improvements?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site